HCNC

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private, Subsidiary

Established: 1977-01-01

Employees: 1K

Market Cap: -

Website: http://www.uzbrussel.be

Clinical Trials

Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer

Conditions: Neoplasm Metastasis

First Posted Date: 2014-08-29

Last Posted Date: 2016-05-11

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 50

Registration Number: NCT02228356

Locations: 🇧🇪
UZ Brussel Radiotherapie dienst, Jette, Brussel, Belgium

Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System

Phase 2

Conditions: Non-Small Cell Lung Carcinoma

Interventions: Radiation: Radiotherapy (Fractionated stereotactic body radiation)

First Posted Date: 2014-08-25

Last Posted Date: 2014-09-09

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 58

Registration Number: NCT02224547

Locations: 🇧🇪
UZ Brussel Radiotherapie dienst, Jette, Brussels, Belgium

Effects of Surface Cooling On Stroke Outcome triaL (COOL)

Conditions: Acute Stroke
Hypothermia

First Posted Date: 2014-06-27

Last Posted Date: 2016-11-17

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 50

Registration Number: NCT02176993

Locations: 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

Not Applicable

Completed

Conditions: Infertility
OHSS

Interventions: Procedure: Intensified luteal phase support for fresh embryo transfer
Procedure: Vitrification with subsequent-cycle embryo thawing/transfer
Device: CryoBioSystem®
Drug: Pregnyl®
Drug: Utrogestan®
Drug: Progynova®

First Posted Date: 2014-05-28

Last Posted Date: 2018-03-09

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 212

Registration Number: NCT02148393

Locations: 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Lisboa, Belgium

Optimal Planning of a Day 3 Cryopreserved(Frozen)-Thawed Embryo Transfer in a Natural Cycle With hCG Administration or After Spontaneous LH Peak?

Phase 4

Completed

Conditions: Supervision of Pregnancy Resulting From In-vitro Fertilization

Interventions: Other: LH peak
Drug: hCG

First Posted Date: 2014-05-23

Last Posted Date: 2019-09-27

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 240

Registration Number: NCT02145819

Locations: 🇧🇪
Centre of Reproductive Medicine CRG, Jette, Brussels, Belgium

Efficacy Study of Segmentation of PGD Treatment

Not Applicable

Conditions: Clinical Pregnancy
Live Birth

Interventions: Procedure: elective cryopreservation of available embryos after PGD
Procedure: PGD and elective fresh embryo transfer plus cryopreservation of supernumerary available embryos after PGD

First Posted Date: 2014-05-08

Last Posted Date: 2014-05-08

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 252

Registration Number: NCT02133950

Locations: 🇧🇪
Centre for Reproductive Medicine UZ Brussel, Jette, Brussels, Belgium

Feasibility of AmbulanCe-based Telemedicine (FACT) Study

Completed

Conditions: Acute Stroke

First Posted Date: 2014-04-21

Last Posted Date: 2014-12-03

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 43

Registration Number: NCT02119598

Locations: 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium

REFRESH: Receptivity Enhancement by Follicular-phase Renewal After Endometrial ScratcHing

Not Applicable

Terminated

Conditions: Infertility

Interventions: Device: Pipelle de Cornier®

First Posted Date: 2014-02-12

Last Posted Date: 2019-12-18

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 200

Registration Number: NCT02061228

Locations: 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium

Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy

Phase 2

Conditions: Acid Reflux Esophagitis
Non-acid Reflux Esophagitis

Interventions: Drug: Lanreotide

First Posted Date: 2014-02-04

Last Posted Date: 2014-02-04

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 10

Registration Number: NCT02054637

Locations: 🇧🇪
University Hospital of Brussels, Jette, Belgium

Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase

Phase 3

Completed

Conditions: Patency
Infection

Interventions: Drug: Taurolidine Heparin
Drug: Taurolidine Urokinase

First Posted Date: 2014-01-14

Last Posted Date: 2018-05-03

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 68

Registration Number: NCT02036255

Locations: 🇧🇪
UZ Antwerpen, Antwerpen, Belgium
🇧🇪
Bracops Hospital, Anderlecht, Brussels, Belgium
🇧🇪
CHU Charleroi, Charleroi, Hainaut, Belgium

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy